Company intelligence / Profile preview

CellVec

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

CellVec is a GMP-certified CDMO specializing in the development and manufacture of custom viral vectors—primarily lentiviral and retroviral—for gene therapy applications. The company provides process development, GMP manufacturing, quality control/assurance, regulatory support, and project management services to enable client products from preclinical through clinical stages. It does not have its own therapeutic pipeline or clinical results but plays an enabling role for advanced therapies developed by its partners.

Modalities: Gene therapyViral vectorBiologic
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on CellVec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellVec.

Explore the full profile